Triptans and SCAD: An Analysis From the WHO Pharmacovigilance Database

J Am Coll Cardiol. 2021 Nov 23;78(21):2129-2130. doi: 10.1016/j.jacc.2021.09.024.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Adverse Drug Reaction Reporting Systems / statistics & numerical data
  • Adverse Drug Reaction Reporting Systems / trends*
  • Coronary Vessel Anomalies / chemically induced*
  • Coronary Vessel Anomalies / diagnosis
  • Coronary Vessel Anomalies / epidemiology
  • Databases, Factual / statistics & numerical data
  • Databases, Factual / trends*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pharmacovigilance*
  • Tryptamines / adverse effects*
  • Vascular Diseases / chemically induced
  • Vascular Diseases / congenital*
  • Vascular Diseases / diagnosis
  • Vascular Diseases / epidemiology
  • World Health Organization*

Substances

  • Tryptamines

Supplementary concepts

  • Coronary Artery Dissection, Spontaneous